Toggle Mobile Navigation

Applied Clinical Trials Shares Updates From CROWN Congress

Our friends over at Applied Clinical Trials Online recently shared updates gleaned from attending ExL Events‘ January 2018 CROWN Congress with their audience. This article exemplifies the benefits of attending an ExL conference and we thank the publication for sharing this information.

Applied Clinical Trials shared highlights from the Congress, including the following sessions:

CRO MARKET CONSOLIDATION
Evaluating the CRO Industry Consolidation and Predictions for What’s Next
David H. Windley, CFA, CPAManaging Director, Healthcare Equity Research, JEFFERIES LLC

PATIENT-CENTERED DIGITAL RECRUITMENT
Creating a Digital Patient Recruitment Ecosystem Focused on Patients to Optimize Engagement
Kevin HudziakEmerging Strategy ConsultantELI LILLY & CO.

ARTICULATING CLINICAL RISKS
Qualifying Clinical Risks to Senior Management, Boards and VCs so They Understand the Trial’s Needs
Evan L. Tzanis, Senior Vice President, Clinical Development and Medical AffairsPARATEK PHARMACEUTICALS

PANEL: BLOCKCHAIN TECHNOLOGY
Optimizing the Efficacy of Clinical Trials With Blockchain
Moderator:
Maria Palombini, Director, Communities and Initiatives Development, Emerging Technology, IEEE STANDARDS ASSOCIATION
Panelists:
Munther Baara, Head of New Clinical Paradigm, PFIZER
Dany DeGrave, Senior Director Innovation Programs and External Networks, SANOFI

…and more!

Click here to read the full article!

For more information on our CROWN Congress, click here!

We’d also like to thank Applied Clinical Trials for mentioning our 9th Proactive GCP Compliance conference, taking place March 19–21.

Now in its ninth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how to effectively build quality risk management approaches into your clinical operations to optimize research, maintain GCP compliance, contain costs and ensure patient safety.

GET INVOLVED!

ExL’s Proactive GCP Compliance attracts an audience of senior-level clinical quality, compliance and operations executives from pharmaceutical, biotechnology, and device companies. If this represents the audience to which you’d like to showcase your company’s services and products, then contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com, to learn more about the sponsorship and exhibition opportunities that are available.

posted in ExL Events News

live chat software